Savant Capital, LLC 10x Genomics, Inc. Transaction History
Savant Capital, LLC
- $13.2 Billion
- Q1 2025
A detailed history of Savant Capital, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Savant Capital, LLC holds 30,052 shares of TXG stock, worth $245,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,052
Previous 40,247
25.33%
Holding current value
$245,524
Previous $577,000
54.59%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TXG
# of Institutions
304Shares Held
109MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.8MShares$105 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$90.8 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$58 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$52.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.38MShares$43.9 Million0.03% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $777M
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...